Affymetrix, Inc. (Nasdaq: AFFX) and Beckman Coulter, Inc. today announced that they have entered into an agreement to offer researchers co-developed products from the market leaders in microarrays and ...
Collaboration to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX), ...
Affymetrix, Inc. (NASDAQ:AFFX) and Leica Microsystems are pleased to announce a world-wide collaboration that automates Affymetrix´ QuantiGene ® ViewRNA ISH Tissue Assay on the Leica BOND RX staining ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced it has launched the Axiom™ Genome-Wide BOS 1 Array, which has 34 percent higher genetic coverage than the current ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has delivered the first custom array designed for a 100,000-sample genotyping project to be performed ...
SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback